Delta Asset Management’s Novo Nordisk NVO Stock Holding History

Delta Asset Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.67K	Buy	100 +40	+67%	+$1.9K	﹤0.01%	513
2025 Q4	$3.05K	Hold	60	–	–	﹤0.01%	524
2025 Q3	$3.33K	Hold	60	–	–	﹤0.01%	527
2025 Q2	$4.14K	Hold	60	–	–	﹤0.01%	501
2025 Q1	$4.17K	Hold	60	–	–	﹤0.01%	504
2024 Q4	$5.16K	Hold	60	–	–	﹤0.01%	493
2024 Q3	$7.14K	Hold	60	–	–	﹤0.01%	469
2024 Q2	$8.56K	Buy	60 +10	+20%	+$1.32K	﹤0.01%	457
2024 Q1	$6.42K	Buy	+50	New	+$5.95K	﹤0.01%	493
2014 Q4	–	Sell	-250	Closed	-$6K	–	573
2014 Q3	$6K	Sell	250 -50	-17%	-$1.15K	﹤0.01%	470
2014 Q2	$7K	Sell	300 -50	-14%	-$1.1K	﹤0.01%	470
2014 Q1	$8K	Sell	350 -190	-35%	-$4.05K	﹤0.01%	435
2013 Q4	$10K	Hold	540	–	–	﹤0.01%	407
2013 Q3	$9K	Hold	540	–	–	﹤0.01%	418
2013 Q2	$8K	Buy	+540	New	+$8.99K	﹤0.01%	434

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Delta Asset Management's NVO Position: Q1 2026 in Review

Delta Asset Management increased its Novo Nordisk (NVO) stake by 67% in Q1 2026, buying an estimated $1.9K and bringing the position to 100 shares worth $3.67K. The position accounts for ﹤0.01% of the portfolio, ranked #513.

Delta Asset Management first reported a position in NVO in Q2 2013 and has held it in 15 quarters since. The position peaked at $10K in Q4 2013. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Delta Asset Management held 100 shares of Novo Nordisk worth $3.67K as of Q1 2026.
Delta Asset Management bought 40 Novo Nordisk shares in Q1 2026, an estimated $1.9K.
Novo Nordisk made up ﹤0.01% of Delta Asset Management's portfolio in Q1 2026, its #513 holding.
Delta Asset Management first reported a position in Novo Nordisk in Q2 2013 and has held it in 15 quarters since.
Delta Asset Management's Novo Nordisk position peaked at $10K in Q4 2013.
1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Delta Asset Management's 13F filing for Q1 2026, filed 11 May 2026.